Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z004811 | — |
No adverse event; Medical assistant reports MMR II was administered to 3 patients following a TE. HCP did not want to evaluate the MMR II for stability, and stated she was already sending it back to VFC she did not need it evaluated. No further details provided. Addit; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 31-OCT-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #Z004811, expiration date: 20-FEB-2027) (dose, route, anatomical location were not provided) as prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date not reported). The operator of the device was a healthcare professional (HCP). Additionally, the HCP did not want to evaluated the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for stability and stated that she (the reporter) already send it back to ''VFC'' she did not needed it evaluated. No adverse events reported. Temperature: Caller reported Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), reached about 70 Fahrenheit (F) Time frame: 3 hours and 15 minutes Previous temperature excursion? YES caller reported the time frame above was cumulative. This is one of the 3 cases received from the same reporter.
sterile diluent